Nonthermal irreversible electroporation for intracranial surgical applications. Laboratory investigation

scientific article

Nonthermal irreversible electroporation for intracranial surgical applications. Laboratory investigation is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3171/2010.5.JNS091448
P698PubMed publication ID20560725

P2093author name stringJohn Robertson
John H Rossmeisl
Paulo A Garcia
Rafael V Davalos
Thomas L Ellis
Natalia Henao-Guerrero
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectelectroporationQ1142521
P304page(s)681-688
P577publication date2010-06-18
P1433published inJournal of NeurosurgeryQ15708886
P1476titleNonthermal irreversible electroporation for intracranial surgical applications. Laboratory investigation
P478volume114

Reverse relations

cites work (P2860)
Q273341147.0-T magnetic resonance imaging characterization of acute blood-brain-barrier disruption achieved with intracranial irreversible electroporation
Q28541799A numerical investigation of the electric and thermal cell kill distributions in electroporation-based therapies in tissue
Q42233592A parametric study delineating irreversible electroporation from thermal damage based on a minimally invasive intracranial procedure
Q39858237A statistical model describing combined irreversible electroporation and electroporation-induced blood-brain barrier disruption
Q30358150Advances in diagnostic and treatment modalities for intracranial tumors.
Q37595430Asymmetric Waveforms Decrease Lethal Thresholds in High Frequency Irreversible Electroporation Therapies
Q41718076Controllable Moderate Heating Enhances the Therapeutic Efficacy of Irreversible Electroporation for Pancreatic Cancer
Q27333617Differential mechanisms associated with vascular disrupting action of electrochemotherapy: intravital microscopy on the level of single normal and tumor blood vessels
Q35325077Dose-dependent ATP depletion and cancer cell death following calcium electroporation, relative effect of calcium concentration and electric field strength
Q27497251High-frequency irreversible electroporation (H-FIRE) for non-thermal ablation without muscle contraction
Q38685276Improving cancer therapies by targeting the physical and chemical hallmarks of the tumor microenvironment
Q34128559Intracranial Nonthermal Irreversible Electroporation: In Vivo Analysis
Q30692995Invited review--neuroimaging response assessment criteria for brain tumors in veterinary patients
Q24596278Irreversible Electroporation: A Novel Image-Guided Cancer Therapy
Q35739515Irreversible electroporation on the small intestine
Q41144902Irreversible electroporation-mediated shRNA knockdown of the HPV18 E6 gene suppresses cervical cancer growth in vitro and in vivo.
Q34313639Irreversible electroporation: an in vivo study with dorsal skin fold chamber
Q38177588Irreversible electroporation: evolution of a laboratory technique in interventional oncology
Q34382616MRI study on reversible and irreversible electroporation induced blood brain barrier disruption
Q39109750Membrane-targeting approaches for enhanced cancer cell destruction with irreversible electroporation
Q37910836Microsecond and nanosecond electric pulses in cancer treatments
Q30415023Multimodality imaging to assess immediate response to irreversible electroporation in a rat liver tumor model
Q26801485Neurosurgical Techniques for Disruption of the Blood-Brain Barrier for Glioblastoma Treatment
Q33788237Non-thermal irreversible electroporation (N-TIRE) and adjuvant fractionated radiotherapeutic multimodal therapy for intracranial malignant glioma in a canine patient
Q37453355Pathology of non-thermal irreversible electroporation (N-TIRE)-induced ablation of the canine brain
Q30412855Physical energy for drug delivery; poration, concentration and activation.
Q45060950Predictive therapeutic planning for irreversible electroporation treatment of spontaneous malignant glioma
Q38951902Pulse timing during irreversible electroporation achieves enhanced destruction in a hindlimb model of cancer.
Q38610113Strategies to target drugs to gliomas and CNS metastases of solid tumors
Q36310547Targeted cellular ablation based on the morphology of malignant cells
Q43061847The Electrode Modality Development in Pulsed Electric Field Treatment Facilitates Biocellular Mechanism Study and Improves Cancer Ablation Efficacy.
Q45066160The Feasibility of Enhancing Susceptibility of Glioblastoma Cells to IRE Using a Calcium Adjuvant
Q37982442Therapeutic potential of irreversible electroporation in sarcoma

Search more.